Therefore, HDAC1 and HDAC2 play a central role in the transcription of NKG2D ligands, and the specific inhibition of HDAC1 and HDAC2 might be a new strategy for treating lung cancer by promoting NK cell-mediated anticancer immunity. The gene discussed is KLRK1; the disease is lung carcinoma.